I recently read a on Axios entitled “Why specialty pharmacies matter”. Based on the title, I was expecting to learn about the important role specialty pharmacies have in providing high quality care but was a little surprised to discover the article was in fact about steep markups on specialty drugs.
While the criticism against high drug costs is valid, this intense focus on pricing has left little room to explore the need for quality. As the healthcare system continuously moves toward , one should be cautious to not be so laser-focused on costs that quality suffers.
Specialty drugs have a lot of great potential but can also carry great risk to patients. Some specialty drugs have a narrow therapeutic index (NTI) which, according to the FDA, means that a mistake in dosage could result in permanent disability or even be life threatening. Specialty drugs, like traditional drugs, can also interact with other drugs or even certain types of food. One limited distribution drug, Kalydeco, which is used to treat certain types of cystic fibrosis, actually interacts with Seville oranges. If someone eats Seville oranges while taking Kalydeco they can be at risk for long-term liver damage.
Given the risk to patients when dealing with high-cost, potent medications, the dispensing of specialty drugs is often limited to a specialty pharmacy by pharmaceutical manufacturers, health plans and their pharmacy benefit managers.
Providing access to high-cost specialty drugs via unprepared pharmacies can place patients in harm’s way. With their training and expertise, specialty pharmacies are leading efforts in their communities across the country to increase patient access to specialty drugs in high-quality safe environments.
URAC is the nation’s leading accreditor of .
To learn more about the role of specialty pharmacies, click here.